Document is current
Any future updates will be listed below
-
Authors
Menghini, Danilo https://orcid.org/0009-0000-7677-9602
Ongini, Esteban https://orcid.org/0009-0005-9091-4483
Devan, Jan https://orcid.org/0009-0009-1544-7511
Bitterli, Pamela https://orcid.org/0009-0005-3897-7807
D’Este, Matteo https://orcid.org/0000-0002-0424-8172
Distler, Oliver https://orcid.org/0000-0002-0546-8310
Farshad, Mazda https://orcid.org/0000-0002-7190-1127
Grad, Sibylle https://orcid.org/0000-0001-9552-3653
Snedeker, Jess https://orcid.org/0000-0002-8115-0275
Dudli, Stefan https://orcid.org/0000-0001-7351-713X
-
Funding
Funding for this research was provided by:
University of Zurich
- License Information
-
More Information
Article History
Received: 15 October 2024
Revised: 16 March 2025
Accepted: 24 March 2025
First Online: 4 April 2025
Declarations
:
: Danilo Menghini (N), Esteban Ongini (3 A- ZuriMED Technologies AG, 4- ZuriMED Technologies AG), Jan Devan (N), Pamela Bitterli (N), Matteo D’Este (N), Oliver Distler (N), Mazda Farshad (3 C-ZuriMED Technologies AG; 4-ZuriMED Technologies AG), Sibylle Grad (N), Jess Snedeker (1-Karl Storz Endoscopy Gmb, ZuriMED Technologies AG; 3 C-Octapharma AG, Novartis AG; 4-ZuriMED Technologies AG; 9-ZuriMED Technologies AG (Board of Directors)), Stefan Dudli (7 A-Aclarion).
